Schwartz Jeffrey Lawrence 4
4 · SpringWorks Therapeutics, Inc. · Filed May 24, 2021
Insider Transaction Report
Form 4
Schwartz Jeffrey Lawrence
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-05-20+6,998→ 6,998 totalExercise: $75.94Exp: 2031-05-20→ Common Stock (6,998 underlying) - Award
Common Stock
2021-05-20+1,106→ 1,106 total
Holdings
- 5,831,307(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents a restricted stock award. The restricted stock award will vest in full on the earlier of (1) May 20, 2022 and (2) the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
- [F2]The options will vest in full on the earlier of (1) May 20, 2022 and (2) the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
- [F3]Represents shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a manager of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.